Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Nausea and Vomiting, Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01913990
What this trial is testing

Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.

Who this might be right for
Emesis
Ottawa Hospital Research Institute 323
Testing effectiveness (Phase 2)Study completedNCT01697579
What this trial is testing

Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Merck Sharp & Dohme LLC 240
Not applicableStudy completedNCT01490060
What this trial is testing

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Who this might be right for
SarcomaChemotherapy-induced Nausea and VomitingEffects of Chemotherapy+1 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT06904235
What this trial is testing

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Who this might be right for
Nausea and Vomiting Chemotherapy-InducedNausea Post Chemotherapy
Helsinn Healthcare SA 95
Testing effectiveness (Phase 2)Study completedNCT01370408
What this trial is testing

Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Northside Hospital, Inc. 85
Large-scale testing (Phase 3)Looking for participantsNCT06208917
What this trial is testing

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Who this might be right for
Pediatric Solid Tumor, Unspecified, Protocol Specific
Yizhuo Zhang 376
Not applicableStudy completedNCT00343863
What this trial is testing

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

Who this might be right for
Male Breast CancerNausea and VomitingStage I Breast Cancer+2 more
University of Washington 41
Testing effectiveness (Phase 2)Study completedNCT03862144
What this trial is testing

NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Consorzio Oncotech 150
Not applicableStudy completedNCT03354741
What this trial is testing

Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children

Who this might be right for
ChildrenChemotherapy-induced Nausea and VomitingMalignant Tumor
Centre Hospitalier Universitaire de Nice 30
Large-scale testing (Phase 3)Study completedNCT04535141
What this trial is testing

Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
UNC Lineberger Comprehensive Cancer Center 91
Large-scale testing (Phase 3)Study completedNCT03674294
What this trial is testing

Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy

Who this might be right for
Gastrointestinal NeoplasmsChemotherapy-induced Nausea and Vomiting
Sun Yat-sen University 248
Large-scale testing (Phase 3)Study completedNCT02135510
What this trial is testing

MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy

Who this might be right for
Solid Tumors
Amsterdam UMC, location VUmc 249
Not applicableStudy completedNCT01344304
What this trial is testing

Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial

Who this might be right for
Colorectal Cancer
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 413
Post-approval studies (Phase 4)Study completedNCT00684463
What this trial is testing

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Who this might be right for
NeoplasmsNauseaVomiting
Merck Sharp & Dohme LLC 59
Large-scale testing (Phase 3)Study completedNCT00003213
What this trial is testing

Drugs to Reduce the Side Effects of Chemotherapy

Who this might be right for
Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Swiss Cancer Institute 267
Testing effectiveness (Phase 2)Study completedNCT03097588
What this trial is testing

Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant

Who this might be right for
Malignant Neoplasm
OHSU Knight Cancer Institute 43
Large-scale testing (Phase 3)Study completedNCT00092196
What this trial is testing

Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)

Who this might be right for
NauseaVomitingBreast Neoplasms
Merck Sharp & Dohme LLC 820
Large-scale testing (Phase 3)Study completedNCT02517021
What this trial is testing

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Helsinn Healthcare SA 405
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07246070
What this trial is testing

Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
AIPING ZHOU 127
Post-approval studies (Phase 4)Study completedNCT04054193
What this trial is testing

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Merck Sharp & Dohme LLC 103
Next Page